Neurome, Inc. conducted genetic research in neurodegenerative diseases. It has additional subsidiaries in the form of Neurome Newco Ltd., which was a Bermuda joint venture with Eli Lilly.
Diablo Management Group (DMG) was retained in 2006 to manage a orderly wind-down of company operations, manage the sale of fixed and IP assets, settle outstanding financial and legal obligations and conduct the liquidation of the Bermuda joint venture.
Manage all facility operations and the orderly wind-down of company operations
Comply with environmental and government regulations throughout the process
Sell the company's fixed assets
Conduct creditor settlement negotiations
Successfully completed operational wind-down
Sold IP to a buyer who continues with promising research (this research may lead to a future return to the estate)